436 related articles for article (PubMed ID: 17998831)
21. Resistin is an inflammatory marker of atherosclerosis in humans.
Reilly MP; Lehrke M; Wolfe ML; Rohatgi A; Lazar MA; Rader DJ
Circulation; 2005 Feb; 111(7):932-9. PubMed ID: 15710760
[TBL] [Abstract][Full Text] [Related]
22. Fecal excretion of alpha 2-macroglobulin: a novel marker for disease activity in patients with inflammatory bowel disease.
Becker K; Niederau C; Frieling T
Z Gastroenterol; 1999 Jul; 37(7):597-605. PubMed ID: 10458008
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of disease activity in IBD at the time of diagnosis by the use of clinical, biochemical, and fecal markers.
Ricanek P; Brackmann S; Perminow G; Lyckander LG; Sponheim J; Holme O; Høie O; Rydning A; Vatn MH;
Scand J Gastroenterol; 2011 Sep; 46(9):1081-91. PubMed ID: 21619483
[TBL] [Abstract][Full Text] [Related]
24. Circulating soluble interleukin-2 receptor alpha and beta chain in inflammatory bowel disease.
Nielsen OH; Ciardelli T; Wu Z; Langholz E; Kirman I
Am J Gastroenterol; 1995 Aug; 90(8):1301-6. PubMed ID: 7639234
[TBL] [Abstract][Full Text] [Related]
25. [The usefulness of reactive protein C in managing patients with ulcerative colitis and Crohn's disease].
López Morante AJ; Sáez-Royuela F; Yuguero del Moral L; Martín Lorente JL; Ojeda Giménez C
Rev Esp Enferm Dig; 1993 Jan; 83(1):5-9. PubMed ID: 8452705
[TBL] [Abstract][Full Text] [Related]
26. Relationship between plasma resistin concentrations, inflammatory chemokines, and components of the metabolic syndrome in adults.
Aquilante CL; Kosmiski LA; Knutsen SD; Zineh I
Metabolism; 2008 Apr; 57(4):494-501. PubMed ID: 18328350
[TBL] [Abstract][Full Text] [Related]
27. Increased leukocyte adhesiveness/aggregation is the single best biochemical indicator of disease activity in adolescent patients with inflammatory bowel disease.
Arber N; Berliner S; Reif S; Dotan I; Liberman E; Aschkenasy M; Vila Y; Gilat T; Bujanover Y
J Med; 1996; 27(5-6):319-31. PubMed ID: 9151200
[TBL] [Abstract][Full Text] [Related]
28. Resistin, a new adipokine, is related to inflammation and renal function in kidney allograft recipients.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Transplant Proc; 2006 Dec; 38(10):3434-6. PubMed ID: 17175295
[TBL] [Abstract][Full Text] [Related]
29. Mean platelet volume: a useful marker of inflammatory bowel disease activity.
Kapsoritakis AN; Koukourakis MI; Sfiridaki A; Potamianos SP; Kosmadaki MG; Koutroubakis IE; Kouroumalis EA
Am J Gastroenterol; 2001 Mar; 96(3):776-81. PubMed ID: 11280550
[TBL] [Abstract][Full Text] [Related]
30. Plasma resistin levels in asthmatics as a marker of disease state.
Larochelle J; Freiler J; Dice J; Hagan L
J Asthma; 2007 Sep; 44(7):509-13. PubMed ID: 17885852
[TBL] [Abstract][Full Text] [Related]
31. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease.
Summers RW; Elliott DE; Qadir K; Urban JF; Thompson R; Weinstock JV
Am J Gastroenterol; 2003 Sep; 98(9):2034-41. PubMed ID: 14499784
[TBL] [Abstract][Full Text] [Related]
32. Plasma citrulline concentration: a reliable marker of small bowel absorptive capacity independent of intestinal inflammation.
Papadia C; Sherwood RA; Kalantzis C; Wallis K; Volta U; Fiorini E; Forbes A
Am J Gastroenterol; 2007 Jul; 102(7):1474-82. PubMed ID: 17459021
[TBL] [Abstract][Full Text] [Related]
33. Neutrophil-elastase in chronic inflammatory bowel disease: a marker of disease activity?
Gouni-Berthold I; Baumeister B; Wegel E; Berthold HK; Vetter H; Schmidt C
Hepatogastroenterology; 1999; 46(28):2315-20. PubMed ID: 10521989
[TBL] [Abstract][Full Text] [Related]
34. Immunoglobulins and IgG subclasses in patients with inflammatory bowel disease.
Gouni-Berthold I; Baumeister B; Berthold HK; Schmidt C
Hepatogastroenterology; 1999; 46(27):1720-3. PubMed ID: 10430330
[TBL] [Abstract][Full Text] [Related]
35. Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells.
Baumgart DC; Metzke D; Schmitz J; Scheffold A; Sturm A; Wiedenmann B; Dignass AU
Gut; 2005 Feb; 54(2):228-36. PubMed ID: 15647187
[TBL] [Abstract][Full Text] [Related]
36. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease.
Karmiris K; Koutroubakis IE; Xidakis C; Polychronaki M; Voudouri T; Kouroumalis EA
Inflamm Bowel Dis; 2006 Feb; 12(2):100-5. PubMed ID: 16432373
[TBL] [Abstract][Full Text] [Related]
37. Elevated serum eotaxin levels in patients with inflammatory bowel disease.
Mir A; Minguez M; Tatay J; Pascual I; Peña A; Sanchiz V; Almela P; Mora F; Benages A
Am J Gastroenterol; 2002 Jun; 97(6):1452-7. PubMed ID: 12094864
[TBL] [Abstract][Full Text] [Related]
38. [Serum bone marker measurements in bone metabolism disorders associated with inflammatory bowel diseases].
Miheller P; Tóth M; Molnár E; Zágoni T; Rácz K; Tulassay Z
Orv Hetil; 2001 Jul; 142(29):1557-60. PubMed ID: 11494747
[TBL] [Abstract][Full Text] [Related]
39. Correlated expression of high-sensitivity C-reactive protein in relation to disease activity in inflammatory bowel disease: lack of differences between Crohn's disease and ulcerative colitis.
Zilberman L; Maharshak N; Arbel Y; Rogowski O; Rozenblat M; Shapira I; Berliner S; Arber N; Dotan I
Digestion; 2006; 73(4):205-9. PubMed ID: 16837810
[TBL] [Abstract][Full Text] [Related]
40. Increased thrombin generation in inflammatory bowel diseases.
Saibeni S; Saladino V; Chantarangkul V; Villa F; Bruno S; Vecchi M; de Franchis R; Sei C; Tripodi A
Thromb Res; 2010 Mar; 125(3):278-82. PubMed ID: 19914688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
